To determine whether implementation of damage control resuscitation (DCR) in patients undergoing damage control laparotomy (DCL) translates into improved survival. Background: DCR aims at preventing coagulopathy through permissive hypotension, limiting crystalloids and delivering higher ratios of plasma and platelets. Previous work has focused only on the impact of delivering higher ratios (1:1:1). Methods: A retrospective cohort study was performed on all DCL patients admitted between January 2004 and August 2010. Patients were divided into pre-DCR implementation and DCR groups and were excluded if they died before completion of the initial laparotomy. The lethal triad was defined as immediate postoperative temperature less than 95 • F, international normalized ratio more than 1.5, or a pH less than 7.30. Results: A total of 390 patients underwent DCL. Of these, 282 were pre-DCR and 108 were DCR. Groups were similar in demographics, injury severity, admission vitals, and laboratory values. DCR patients received less crystalloids (median: 14 L vs 5 L), red blood cells (13 U vs 7 U), plasma (11 U vs 8 U), and platelets (6 U vs 0 U) in 24 hours, all P < 0.05. DCR patients had less evidence of the lethal triad upon intensive care unit arrival (80% vs 46%, P < 0.001). 24-hour and 30-day survival was higher with DCR (88% vs 97%, P = 0.006 and 76% vs 86%, P = 0.03). Multivariate analysis controlling for age, injury severity, and emergency department variables, demonstrated DCR was associated with a significant increase in 30-day survival (OR: 2.5, 95% CI: 1.10-5.58, P = 0.028). Conclusion: In patients undergoing DCL, implementation of DCR reduces crystalloid and blood product administration. More importantly, DCR is associated with an improvement in 30-day survival. (Ann Surg 2011;254:598-605) B eginning with its early descriptions by Stone et al, Feliciano et al, and others and codified by Rotondo et al, damage control laparotomy (DCL) allows the trauma surgeon a viable option in dealing with the exsanguinating trauma patient. 1-5 When first described,
DCL was performed in approximately 5% of trauma laparotomies. DCL is an abbreviated resuscitative surgical approach with the primary goal being the rapid control of hemorrhage and contamination focused on restoring normal physiology at the expense of normal anatomy. Patients often undergo temporary closure of the abdominal wall and are rapidly transported to the intensive care unit (ICU) for correction of coagulopathy, hypothermia, and acidosis. 6 At the same time the DCL process was being popularized, blood bankers replaced whole blood with component therapy. 7 This change occurred without adequate clinical efficacy data. Simultaneously, Carrico and Shires proposed that crystalloid therapy was an effective initial resuscitative fluid. 8 Unfortunately, clinicians used this cheap and ubiquitous product indiscriminately. At the same time, Shoemaker and colleagues established the concept of supranormal resuscitation and argued for the use of large volumes of crystalloid in resuscitating trauma patients. 9, 10 Although this practice led to higher oxygen delivery, it also increased extravasations of fluid, tissue edema, and higher overall blood pressures. 11 Taken together, these separate but convergent processes coalesced to generate an iatrogenic resuscitation injury, resulting in edematous patients, an epidemic of open abdomens, and significant mortality and morbidity. 6, 12 In 2005, damage control resuscitation (DCR) was developed by military clinicians who had seen firsthand the benefits of whole bloodbased resuscitation in severely injured patients. 13, 14 DCR soon gained popularity in the civilian centers as combat surgeons demonstrated how patients resuscitated with this approach were less edematous and coagulopathic postoperatively. DCR aims at preventing or reversing coagulopathy through permissive hypotension, limiting crystalloids, and delivering higher ratios of plasma and platelets. Subsequently, multiple authors have demonstrated favorable outcomes associated with plasma and platelet ratios approximating whole blood including decreases in costs of care, blood product utilization, organ failure rates, open abdomens, and 6-and 24-hour and 30-day mortality. [15] [16] [17] [18] [19] Although significant attention has been paid to the ratios of plasma and platelets, insufficient focus have been paid to the other 2 components of DCR: permissive hypotension and minimizing crystalloidbased resuscitation. Given the severity of injury and gross disturbances in physiology associated with the DCL patient, we chose this population to assess the full impact of the application of DCR on survival. Therefore, the purpose of this study was to determine whether implementation of all 3 tenets of DCR would translate to improved survival in DCL patients. facility within Texas Medical Center. The trauma center currently admits over 5000 trauma patients annually with the most severely injured cared for in our 23-bed shock-trauma ICU.
Selection of Subjects
Approval was obtained from the University of Texas at Houston institutional review board. This was a single-center, retrospective cohort study of trauma patients admitted to Memorial Hermann Hospital using the institution's Trauma Registry of the American College of Surgeons database. We evaluated all adult trauma patients admitted between January 2004 and August 2010 who underwent immediate exploratory laparotomy. These were defined by proceeding directly from emergency department (ED) to operating room (OR). We then evaluated only the subgroup of these patients who were managed by DCL techniques. In accordance with the expedited approval process, protected populations such as minors (age < 18 years), prisoners, and pregnant women were excluded from this study. Patients were also excluded from analysis if they received 5 minutes or more cardiopulmonary resuscitation before the OR or died in the ED or OR during their procedure.
Although our institution has long been using higher plasma and platelet ratios in our resuscitations, an emphasis on the other 2 critical components of DCR (permissive hypotension, minimizing crystalloid administration) was not practiced before 2009. 20, 21 Beginning in January 2009, our faculty began to champion the adoption and consistent implementation of these other 2 components. From this time point, DCL resuscitations were discussed at our morning report (sign-out) among the trauma and surgical critical care faculty, fellows, and residents. Noncompliance and "outliers" were identified in a real-time fashion and feedback provided to all involved parties (prehospital, ED, OR, trauma, and surgical critical care personnel). This was followed with structured and directed educational conferences, grand rounds presentations, and individual provider educational interventions consistent with previously published data. 22 As such, 2 groups were generated for comparison. The pre-DCR group consisted of those patients who were managed before DCR implementation (January 1, 2004, to December 31, 2008) . The DCR group was made up of those patients who were managed after implementation of DCR (January 1, 2009, to August 31, 2010).
Data Collection
Data collected included demographics, mechanism of injury, abbreviated injury scores, injury severity scores, specific injury profiles, procedures performed, fluids and blood products administered, vital signs, blood gases, coagulation profiles, intra-abdominal pressures, time to closure, complication rates, and 24-hour and 30-day survival.
Definitions
DCL was defined as any emergent trauma laparotomy that resulted in temporary abdominal closure, regardless of procedures performed or placement of abdominal packing. Emergent trauma laparotomies were identified if the primary injury was traumatic in nature and if the patient went to the OR directly from the ED. As no objective DCL protocol was in place, the decision to implement damage control was dependent on the surgeon's gestalt in the ED or OR. 12 In all cases, the patients were resuscitated in the ICU before attempting a second-look operation. The take-back operation afforded the opportunity to perform definitive repairs and, if possible, primary fascial closure. Primary fascial closure in this study was defined as approximation of the fascial edges and does not include synthetic or biological mesh closure without fascial approximation.
The identification of prehospital vital signs was obtained through a review of ground or air transport documentation. ED vital signs were defined as the initial set of vital signs captured and documented in the trauma bay. All patients had a single comprehensive ED laboratory panel obtained in the ED. The results of these laboratories were used for populating the ED laboratory value data fields through an electronic medical records data query. OR vital signs were the initial set of vital signs documented in the electronic medical records. Similarly, the OR laboratory results were defined as the initial values obtained after arrival in the operating theater. The ICU vital signs and laboratory values were defined as the initial values obtained immediately after patient arrival in the ICU. Peak intra-abdominal pressures were defined as the highest transduced bladder pressure recorded in the electronic medical record before the first take back.
Prehospital, ED, and OR crystalloid administration were defined as the sum of all normal saline, lactated Ringer's solution, and plasmalyte received while in these locations. Intraoperative colloids (albumin, tromethamine, and hetastarch) were also recorded. Prehospital, ED, and OR blood products (red blood cells [RBC], plasma, and platelets) were defined as those products received while in these hospital locations. Twenty-four-hour blood product calculations were defined as the total number of products received 24 hours from time of arrival to the hospital. This included blood in the trauma bay, OR, and postoperatively up to the 24-hour postadmission time point.
The lethal triad was defined by the initial laboratory values and vital signs upon arrival to the ICU. Acidosis was defined by an initial pH of less than 7.30. Hypothermia was defined as temperature less than 95.0 degrees Fahrenheit. Coagulopathy was defined as an international normalized ratio (INR) value of more than 1.5.
Organ dysfunction and multiple organ failure were defined using the Denver Multiple Organ Failure (MOF) scoring system. 23 This system evaluates 4 organ systems: pulmonary, hepatic, renal, and cardiac. Organ dysfunction is graded on a scale from 0 to 3. The pulmonary score is determined by the PaO 2 /FiO 2 ratio. PaO 2 /FiO 2 ratios greater than 208 received a zero (0) point whereas ratios of 208 to 165, 165 to 83, and less than 83 received 1, 2, and 3 points, respectively. The renal system was graded by serum creatinine level in mg/dL: 0 points for less than 1.8, 1 point for 1.8 to 2.5, 2 points for 2.5 to 5.0, and 3 points for more than 5.0 mg/dL. The hepatic score was calculated by total serum bilirubin level in mg/dL: 0 points for bilirubin less than 2.0, 1 point for 2.0 to 4.0, 2 points for 4.0 to 8.0, and 3 points for bilirubin more than 8.0 mg/dL. Cardiac dysfunction was graded based on inotropic support and cardiac index. No inotropes and cardiac index of more than 3.0 L/min/m 2 yielded a score of zero; whereas, minimal inotropic support or cardiac index less than 3.0 yielded a score of 1. Moderate and high dose inotropic received scores of 2 and 3, respectively. Scores that were not recorded were assumed to be normal and were calculated as zero. For multiple organ failure, the MOF score was calculated as the sum of the simultaneously obtained individual organ scores on each hospital day. Single system organ failure was defined as an organ failure grade greater than 0 and MOF was defined as a total score of 4 or higher. 24, 25 Hospital length of stay (in days), ICU length of stay (in days), and ventilator-free days, are expressed in calendar days. Ventilator free-days were calculated by the days alive (up to 28 days) and free of the ventilator. 26, 27 The incidences of 24-hour and 30-day mortality were recorded and evaluated from the in-patient and clinic charts.
Statistical Analysis
Continuous data are presented as medians with 25th and 75th interquartile range (IQR) with comparisons between groups performed using the Wilcoxon rank sum (Mann-Whitney U test). Categorical data are reported as proportions and, where appropriate, tested for significance using χ 2 plasma, platelets, and cryoprecipitate. As well, we evaluated the incidence of lethal triad components.
Purposeful regression modeling was then used to construct a multivariate logistic regression model evaluating 30-day survival. This was done using the technique of purposeful selection of covariates described by Hosmer and Lemeshow. 28 In an effort to minimize the risk of falsely identifying significant results with multiple comparisons, all variables were prespecified and judged a priori to be clinically sound. These independent variables included age, sex, injury severity (ISS), ED vitals and laboratories, prehospital and hospital fluid administration and transfusions. After this, the variables were entered into step-wise regression that generated 4 variables of significance (age, ED systolic blood pressure [SBP], ED base deficit, ED INR value). These were then applied to a multivariate logistic regression analysis evaluating these 4 variables and exposure to DCR. STATA Statistical software (version 10.1; College Station, TX) was used for analysis.
RESULTS
During the 6-year study period, 25,069 adult trauma patients were admitted. Of them, 1514 underwent emergent laparotomy for trauma whereas 197 met our predetermined exclusion criteria, leaving 1317 patients for analysis during the study period ( Fig. 1 ). A total of 927 patients underwent a single-staged procedure and 390 (30%) underwent DCL. The rates of DCL were consistent between the time frames, with a range of 29% to 37% for 2004 to 2008 and 29% to 36% for 2009 to 2010. These 390 DCL patients were the focus of this resuscitation study. Among these DCL patients, 282 (72%) were admitted before DCR implementation (pre-DCR group) and 108 (28%) were admitted during the DCR period (DCR group). This equated to approximately 4.6 DCL patients per month during the pre-DCR period and 5.4 DCL patients per month during the DCR period. Demographics and injury severity were similar between the 2 DCL groups ( Table 1) . Although the prehospital SBPs were the same, the blood pressure in the DCR group was lower on arrival to the ED and to the OR ( Table 2 ). As well, the field and ED arrival Glasgow coma scale were lower in the DCR patients than the pre-DCR group. Interestingly, the hear rate (HR) was higher in the pre-DCR group. Consistent with the tenet of minimizing crystalloids, the DCR group received less fluid in the field, in the ED, and in the OR. Despite this, the DCR group had less base deficit in the ED and OR. The DCR patients also received more ED plasma but less intraoperative blood products. Intraoperative times were also similar between the groups (median time of 98 minutes in the DCR group vs 109 minutes pre-DCR; P = 0.130). However, in-hospital use of recombinant factor VIIa was significantly lower in the DCR group (6% vs 17% in the pre-DCR patients; P < 0.001).
Consistent with our practice across the time frames, there were no differences in early (ED and OR) ratios of RBC: plasma (median ratio of 1.08 in DCR vs 1.19 pre-DCR group; P = 0.785). Evaluating by years, 2004 to 2008 had a RBC: plasma range of 1.01 to 1.35 whereas 2009 to 2010 had a range of 1.03 to 1.19. As for other tenets of DCR, there was less change from ED arrival to ICU arrival blood pressures in the DCR group compared to pre-DCR (median delta SBP 1 mm Hg with IQR -16 to 24 vs 18 mm Hg with IQR -7 to 47; P < 0.001). Despite receiving less crystalloid fluid volumes and less blood products in the OR, DCR patients arrived to the ICU warmer, less acidotic, and less coagulopathic ( Table 3 ). As such, DCR patients had less evidence of the lethal triad upon ICU arrival (80% vs 46%, P < 0.001). The range for the pre-DCR years was 78% to 87% and that of the DCR years was 44% to 51%. The DCR group was also less likely to have all 3 components of the triad present upon ICU arrival (3% vs 12%, P < 0.001). Importantly, 24-hour crystalloid volumes, and RBC, plasma, and platelet transfusions were reduced after implementation of DCR. Though numeric reductions were observed in acute renal failure, acute respiratory distress syndrome (ARDS), and multiorgan failure among the DCR population, these values trended toward but did not reach statistical significance.
Univariate analysis demonstrated improvement in 24-hour and 30-day survival among those on the DCR group (Table 3) . Before 2009, the 30-day mortality rates were consistent and were in the range of 23% to 27%. A multivariate logistic model was then developed predicting 30-day survival (dependent variable). After controlling for age and arrival base deficit, INR, and blood pressure, DCR was independently associated with a 2.5-fold increased odds of 30-day survival ( Table 4 ). 
DISCUSSION
Numerous authors have demonstrated favorable outcomes with the DCR approach to resuscitation. [14] [15] [16] [17] [18] [19] 20, [29] [30] [31] However, these publications have focused primarily on the plasma and platelet ratio component of DCR while ignoring the other tenets. In addition, several busy centers have questioned the survival benefit of these ratios. These authors have suggested that patients achieving 1:1:1 ratios are simply living long enough to receive them and those who die early are not alive long enough to receive 1:1:1. 31, 33 As early as 2002, we had already began delivering higher ratios of plasma and platelets, but we have now demonstrated that the prospective application of limited crystalloid and permissive hypotension is possible and is associated with improved outcomes. 19 When all 3 tenets of DCR are applied, despite the use of early and high ratio plasma and platelets, a reduction in overall RBC, plasma, and platelet use is observed. More importantly, we noted an associated increase in 24-hour and 30-day survival. This survival difference remained even after controlling for age and arrival vital signs and laboratory values.
Large volume crystalloid-based resuscitations are associated with increased frequency of and longer time to recovery from acute respiratory distress syndrome and higher mortality. 6, 33, 35 Systemically, the incidence of pulmonary complications, gastrointestinal dysmotility, and coagulation disturbances are higher as the volume of early crystalloid infusion is increased. Even when controlling for shock and severity of injury, the volume of crystalloid infused is associated with increased risk of developing intra-abdominal hypertension and abdominal compartment syndrome. 12, [36] [37] [38] [39] [40] [41] [42] [43] In addition, investigators from Los Angeles County have recently demonstrated that infusing as little as 10 L of crystalloids in the first 3 days after injury is associated with a 5-fold increased risk for colonic anastomotic leaks. 44 Moreover, when Ley and colleagues 45 evaluated their trauma outcomes, they found that as little as 1.5 L of fluid in the ED was associated with a 2-fold increased risk in mortality (even after controlling for ISS and arrival vital signs). 45 Through a dedicated and recurring educational process, we were able to reduce the amount of crystalloids infused in the prehospital, ED, OR, and ICU settings. By using plasma as the primary resuscitation fluid and broad application of DCR principles, we noted an associated decrease in 24-hour crystalloids administration by almost 9 L in the first 24 hours after admission. Intuitively, one would assume that as crystalloid use went down that blood product use would increase. However, we found just the opposite. All blood product use decreased over the same time frame. Coincident with this change in resuscitative fluids, all measured physiologic variables improved.
In 1994, Bickell and colleagues 46 published their results from a randomized trial of prehospital hypotensive resuscitation in patients sustaining penetrating torso injuries. 46 When compared to the standard group, those randomized to receive no fluids until arriving in the OR had less intraoperative blood loss, shorter length of stay, and increased survival. As with our findings, these investigators noted similar field SBP but lower blood pressure on ED arrival. Eight years later, Dutton and colleagues 47 conducted a randomized trial of hypotensive resuscitation beginning in the ED. Although there was no survival difference detected in this small study, the authors demonstrated that aiming for a SBP of 70 mm Hg (vs >100 mm Hg) was safe in patients arriving with evidence of hemorrhage. Morrison and colleagues 48 have recently lent support to intraoperative hypotensive resuscitation. These investigators randomized patients in hemorrhagic shock to target mean arterial pressures (MAP) of 50 or 65 mm Hg. In this pilot study, investigators from Ben Taub General hospital found that targeting resuscitation to a MAP of 50 mm Hg results in reduced intraoperative RBC and plasma transfusions, less postoperative coagulopathy, and higher 24-hour survival. The current study noted that SBP measurements on arrival to the ED, OR, and ICU were lower in the DCR group. Similar to what are colleagues at Ben Taub noted, the DCR group had less blood transfusions, hypothermia, coagulopathy, and acidosis and had improved survival.
Although we feel that the current data support the adoption of DCR, this study has several limitations. First, and most notable, this is not a randomized study. Although we implemented the DCR concept in a prospective fashion through an educational initiative, such a pre-/postintervention study design is not a substitute for a well-designed randomized trial. In addition, though the groups seem similar in all baseline comparisons (Table 1) , differences among the groups, which are not measured or captured in this study, may very well exist. As well, this was not a multicenter investigation but rather the results from a single institution. In addition, the indication or use of DCL was based solely on trauma surgeon judgment and nothing else. No protocols or guidelines were (or are) in place at our institution. However, all of our faculty are full-time trauma surgeons at a busy, level-1 ACS trauma center and all are board certified in Surgery and Surgical Critical Care. Finally, we focused our study on a select group of patents (those undergoing DCL). Therefore, DCR may not be suitable or helpful in those not requiring DCL. However, when we did look at those undergoing emergent laparotomy (but not DCL), we noted similar favorable findings in resuscitation endpoints and avoidance of the lethal triad. Though these outcomes did not result in improved survival, no evidence of harm was noted in those treated with the DCR strategy.
CONCLUSION
Beginning in 2003, military clinicians started developing and implementing the concepts of DCR in the Iraq theater of operations. Subsequently, leaders in trauma, critical care, and emergency medicine, anesthesia, and transfusion medicine called on those caring for the injured patient to reconsider their approach to resuscitation. 13, 14 These editorials outlined the concept of DCR. 49, 50 Although many civilian centers began to embrace the DCR concept, most only applied the principle of higher plasma and platelet ratios. Applying all 3 tenets, this study identified a reduction in crystalloid and blood administration in patients managed with DCR. More importantly, the DCR strategy was associated with a 2.5-fold increased odds in 30-day survival. 
DISCUSSANTS D. Trunkey (Portland, OR):
In this article looking at comparative effectiveness research, the authors compared 2 groups of patients: One submitted to damage control laparotomy, and then, adding to this group, the damage control resuscitation. There are 3 components to the DCR as outlined by the author: The ratio of plasma and platelets, permissive hypotension, and minimizing crystalloid. One of these, the ratio of plasma and platelets, has been extensively used by our military in the last 6 years. However, I take issue on a historical basis about permissive hypotension and minimizing crystalloid. This too is described by our military, but it was in 1918 by Walter B. Cannon. He also wanted to minimize colloid but the colloid that he minimized was gum guaiac because plasma was not readily available at that time.
A major strength of this article with the well-defined metrics, looking at vital signs during prehospital care, ED care, vital signs, including ED laboratory results, OR vital signs, laboratory results, ICU vital signs, and laboratory results. In addition, in the ICU, they looked at peak intra-abdominal pressure, which was very useful. However, in my opinion, a shortcoming of their methodology was the failure of obtaining a lactate level in the ER and in the OR; although, they did do blood gases and got base excess. Base excess is a derived number whereas lactate is a real number. But which one would be better?
Also, in the previous study, there was a fairly significant high use of crystalloids. I would ask the authors to give their impression of when CVP is indicated and whether it even needs to be done if it does not give us useful information.
I have several questions. The crystalloid fluids used in this study, included normal saline, Ringer's lactate and Plasmalyte. I think we are to the point now that we should abandon normal saline because it has an excess of 44 milliequivalents of chloride, which may contribute to the acidosis because the chloride is a proton acceptor. The use of Ringer's may have both negative and positive effects. In theory, it should cause or reduce acidosis if the liver is being perfused. On the contrary, it could contribute to lactic acidosis if the lactate is not converted to bicarb. In my opinion, a balanced-salt solution, like Plasmalyte, might be superior but we have no comparative randomized trials comparing balanced-salt solution and the so-called modified University of Wisconsin solution. Could you please comment on that?
One of the most impressive results is the 2.5-fold increases in the odds of living at 30 days. The use of plasma also reduced the use of crystalloid by 9 L and this was not associated with an increased use of blood. I believe the chosen systolic blood pressure (70 millimeters of mercury) may be too low. In his study in World War I, Cannon showed good organ perfusion down to 80 millimeters of mercury; but he fudged in regard to his resuscitative guideline, which was 85 millimeters of mercury. I know the military also uses a palpable radial pulse as adequate perfusion. Most organs will autoregulate down to 60 millimeters of mercury, so 70 might be a reasonable number. But I would like the authors' impressions of this.
Response From B. A. Cotton:
With respect to your first comments about lactate, we think the strengths of lactate are real, in combination with the base deficit, and in identifying the trajectory of that patient. We have recently added lactate, in addition to the base deficit, to our emergency department trauma resuscitation laboratories-all of our major trauma activations are now getting lactate and base deficit, and a pH.
To your second point, regarding the utility of catheter-based resuscitation, when we are chasing numbers, we are chasing oxygen delivery and such with these high resuscitation strategies. However, now that we have ramped back a lot of the fluids and are focusing more on a whole-blood-based resuscitation, we use intravenous pressure monitors much less. We still will occasionally use other variables and other laboratory measurements, such as a pro-BMP, or brain natriuretic peptide, looking at atrial stress, which has been shown to have some benefit with resuscitation. I think looking at them more as a trajectory not as an absolute is beneficial.
Also, with respect to the saline and lactated Ringer's, we have made some headway in our emergency department, prehospital, and even ORs with what fluid is chosen in the operating theater. We prefer a balanced-salt solution. At our facility and the greater Houston area, much of the reason for choosing NS over LR in the prehospital and ED setting, was based on the fear or at least the fiction, that you cannot give LR and blood through the same line because a precipitate would cause all kinds of problems. Now that we have gotten past that fear and pushed the data on this, we have been able to change our fluids back to more of a balanced-salt solution.
Finally, with respect to the blood pressure, these were, again, goals and lofty ideals to try to get to a lower blood pressure and allow it when we had a good, palpable pulse, when we had someone who was at least potentially mentating, making urine, and looking at those type outcomes. Recently, in The Journal of Trauma, the Houston group Mattox looked at permissive hypotension and found that there was no difference in organ failure comparing maps of 50 versus 65. But there was a reduction in overall blood product use and a reduction in coagulopathy, and these patients were arriving more physiologically stable to the ICU. They are still collecting data and looking for a survival benefit.
DISCUSSANTS P. Rhee (Tucson, AZ):
Damage control resuscitation is basically avoidance of crystalloids, which causes inflammation and it makes sense to replace whole blood with something that looks similar. Adopting this, we found that our abdominal compartment rate went to zero last year. Do you have any data on what your abdominal syndrome is now? Another question is, what is your rate of damage control laparotomy?
Of the people who underwent damage control laparotomy after the adoption of damage control resuscitation in your data, 46% of those people had the lethal triad. What are your indications for damage control laparotomy? Preventing the iatrogenic problem of open abdomen would be good. Is not it better to just do the job correctly the first time?
Response From B. A. Cotton:
With respect to your questions on the abdominal pressures, the peak intraabdominal pressures were lower in our damage control resuscitation phase. And, similar to the acute renal failure, acute respiratory distress syndrome and multiorgan failure, there was an absolute number reduction in our abdominal compartment syndrome DCR Reduces Fluids and Improves Survival events. But, again, sample size yielding it did not give a statistical significance.
As far as how many resuscitations end up with a damage control laparotomy, our rates have generally trended down from the pre-DCR phase to the DCR phase. You can look at the overall being about 30% to 32% in our whole population. But if you break it down in the last 2 years, it is closer to a 23% to 24% range.
As far as the DCL definitions and indications, they are faculty driven, and obviously, not uniformly indicated. At morning report, the majority of our group agrees on these. There are occasional ones where we think it was applied a little too liberally. But again, as stated more in the methods section of our article, there was no strict definition or indications for initiating damage control laparotomy.
DISCUSSANTS C. Lucas (Detroit, MI):
Dr. Cotton, I have 3 questions. On the basis of the experiences in Detroit, 32% damage control laparotomy is a huge number. I am curious to know whether we are looking at apples and oranges. Were the same attending surgeons making decisions in the operating room for the first half and the second half of the studies?
My second question has to do with the definition of the damage control resuscitation. Would you please tell us, what was the exact plasma to red cell ratio? I am not interested in what it was for 24 hours; I am only interested in what it was during the operation. My third question is whether you are measuring factors. We all know that you are giving plasma to restore your procoagulants. Please tell us the measurements of your standard coagulation times and your procoagulants during operation.
Response From B. A. Cotton:
As far as your first point, the large number of damage control laparotomies, some might be applied a little bit more liberally than others as a matter of convenience when multiple alert scenarios are going off with multiple operating rooms in use and not enough trained people to be taking care of them. But at our morning report process, the majority of damage control laparotomies are felt to be indicated. I cannot say that the percentage of damage control laparotomies has decreased over the course of that period. In fact, they have stayed a remarkably consistent percentage of our emergent laparotomies.
With respect to your questions about the attendings, there definitely was a change in the faculty recruitment and exit. Approximately half of the attendings were present during the pre-DCR phase and about half of the same attendings were present during the post-DCR phase. A core of about 4 or 5 that was there during the prephase, was still there during the postphase and are there currently.
I do not remember the specific ratios from the operating room, but when I looked at ED and OR combined, the ratio of red cell to plasma was 1.08 in the DCR group and 1.19 in the pre-DCR group. So, slightly more red cells than plasma in that group. By the time you get to the ICU, it was caught up to one to one, and those were not statistically different between the pre and post.
